Cardiometabolic Syndrome: An Update on Available Mouse Models

Abstract

Cardiometabolic syndrome (CMS), a disease entity characterized by abdominal obesity, insulin resistance (IR), hypertension, and hyperlipidemia, is a global epidemic with approximately 25% prevalence in adults globally. CMS is associated with increased risk for cardiovascular disease (CVD) and development of diabetes. Due to its multifactorial etiology, the development of several animal models to simulate CMS has contributed significantly to the elucidation of the disease pathophysiology and the design of therapies. In this review we aimed to present the most common mouse models used in the research of CMS. We found that CMS can be induced either by genetic manipulation, leading to dyslipidemia, lipodystrophy, obesity and IR, or obesity and hypertension, or by administration of specific diets and drugs. In the last decade, the ob/ob and db/db mice were the most common obesity and IR models, whereas Ldlr−/− and Apoe−/− were widely used to induce hyperlipidemia. These mice have been used either as a single transgenic or combined with a different background with or without diet treatment. High-fat diet with modifications is the preferred protocol, generally leading to increased body weight, hyperlipidemia, and IR. A plethora of genetically engineered mouse models, diets, drugs, or synthetic compounds that are available have advanced the understanding of CMS. However, each researcher should carefully select the most appropriate model and validate its consistency. It is important to consider the differences between strains of the same animal species, different animals, and most importantly differences to human when translating results.

The Effects of Bifidobacterium Probiotic Supplementation on Blood Glucose: A Systematic Review and Meta-Analysis of Animal Models and Clinical Evidence

“…Diet-induced obesity (DIO) or transgenic (TrG) obesity models were classified separately from MetS models to differentiate obesity from the cluster of additional criteria that define MetS [ 25 ]. To be classified as a model of MetS, the animal model needed to establish obesity in addition to ≥1 MetS criteria, such as dyslipidemia, hypertension, or hyperglycemia (e.g., obese Zucker rats reliably establish hyperlipidemia and insulin resistance) [ 25 , 26 ]. T2D animal models included diet-induced T2D, TrG strains, or chemically induced T2D with streptozotocin (STZ).…”

Methylglyoxal and Advanced Glycation End Products (AGEs): Targets for the Prevention and Treatment of Diabetes-Associated Bladder Dysfunction?

“…The main T2DM models that result in hyperinsulinemia and insulin resistance rely on allowing animals free access to diets highly enriched in fats [101,102]. In addition to producing the classical obesity-associated vascular dysfunction, male mice fed high-fat diets progress to an overactive bladder phenotype, as evidenced mainly by filling cystometry in anesthetized and awake rats and mice [103][104][105].…”